Figure 2
From: Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
Survival probability in weeks of patients with CD34+ and CD34− GISTs.
Figure 2 | Scientific Reports
From: Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
Survival probability in weeks of patients with CD34+ and CD34− GISTs.
